Weightbearing Strategies for Knee Injury Rehab
Trial Summary
What is the purpose of this trial?
This is a prospective randomized controlled trial with the purpose to determine if patients undergoing fibular collateral ligament (FCL) reconstruction alone or combined FCL and anterior cruciate ligament (ACL) reconstructions can safely begin full controlled weightbearing for the first six weeks after surgery.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications. Please consult with the trial coordinators for more details.
What data supports the effectiveness of the treatment for knee injury rehab?
Research shows that rehabilitation after ACL reconstruction, including physical therapy and specific exercise regimens, is effective in restoring knee function. Studies highlight the importance of achieving knee symmetry in motion and strength, with 100% of patients achieving normal knee extension and 97% achieving normal knee flexion using the Knee Symmetry Model.12345
Is weightbearing after knee ligament reconstruction generally safe?
What makes the Weightbearing Strategies for Knee Injury Rehab treatment unique?
This treatment is unique because it explores early weightbearing strategies specifically after fibular collateral ligament reconstruction, which is not well-defined compared to the more established early weightbearing protocols for ACL reconstruction. It aims to enhance rehabilitation by focusing on weightbearing exercises that protect the knee and improve neuromuscular function.34101112
Research Team
Robert F LaPrade, MD, PhD
Principal Investigator
Twin Cities Orthopedics
Eligibility Criteria
This trial is for males and females aged 14 to 60 who are undergoing fibular collateral ligament (FCL) reconstruction, with or without anterior cruciate ligament (ACL) surgery. Participants must be able to follow the study plan and give informed consent. It's not for those with certain other knee surgeries, pregnant individuals, under 14 or over 60 years old.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo fibular collateral ligament reconstruction and follow one of two rehabilitation protocols: partial weightbearing or full controlled weightbearing for the first six weeks post-surgery.
Follow-up
Participants are monitored for safety and effectiveness, including measurements of varus gapping, pain, edema, range of motion, and quadriceps strength.
Long-term follow-up
Participants' outcomes are assessed through patient-reported outcome scores and other measures to evaluate long-term recovery.
Treatment Details
Interventions
- Anterior Cruciate Ligament Reconstruction
- Fibular Collateral Ligament Reconstruction
- Physical Therapy
Anterior Cruciate Ligament Reconstruction is already approved in United States, European Union, Canada, Japan for the following indications:
- Knee instability due to ACL tear
- Combined ACL and meniscal injuries
- Chronic ACL deficiency
- Knee instability due to ACL tear
- Combined ACL and meniscal injuries
- Chronic ACL deficiency
- Pediatric ACL injuries
- Knee instability due to ACL tear
- Combined ACL and meniscal injuries
- Chronic ACL deficiency
- Knee instability due to ACL tear
- Combined ACL and meniscal injuries
Find a Clinic Near You
Who Is Running the Clinical Trial?
Twin Cities Orthopedics
Lead Sponsor